bioRxiv · 10.1101/2024.11.24.625079
Secretory leukocyte protease inhibitor influences periarticular joint inflammation in B. burgdorferi-infected mice
Abstract
Lyme disease, caused by Borrelia burgdorferi, is the most common tick-borne infection in the United States. Arthritis is a major clinical manifestation of infection, and synovial tissue damage has been attributed to the excessive pro-inflammatory responses. The secretory leukocyte protease inhibitor (SLPI) promotes tissue repair and exerts anti-inflammatory effects. The role of SLPI in the development of Lyme arthritis in C57BL/6 mice, which can be infected with B. burgdorferi, but only develop mild joint inflammation, was therefore examined. SLPI-deficient C57BL/6 mice challenged with B. burgdorferi had a higher infection load in the tibiotarsal joints and marked periarticular swelling, compared to infected wild type control mice. The ankle joint tissues of B. burgdorferi-infected SLPI-deficient mice contained significantly higher percentages of infiltrating neutrophils and macrophages. B. burgdorferi-infected SLPI-deficient mice also exhibited elevated serum levels of IL-6, neutrophil elastase, and MMP-8. Moreover, using a recently developed BASEHIT (BActerial Selection to Elucidate Host-microbe Interactions in high Throughput) library, we found that SLPI directly interacts with B. burgdorferi. These data demonstrate the importance of SLPI in suppressing periarticular joint inflammation in Lyme disease.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Yu, Q., Tang, X., Hart, T., Homer, R., Belperron, A. A., Bockenstedt, L., Ring, A., Nakamura, A., Fikrig, E.. 2024-11-25. Secretory leukocyte protease inhibitor influences periarticular joint inflammation in B. burgdorferi-infected mice. https://doi.org/10.1101/2024.11.24.625079
Cite the original work for its findings. Save a collection to share your selection of sources.